Delphia takes its name from Greek history. Etched on the walls of the temple of Apollo in the city of Delphi was the phrase “ nothing in excess,” a concept the biotech is applying to cancer ...

“Delphia’s activation lethality platform is one of the most innovative approaches in cancer drug development and offers an excellent foundation to build a differentiated oncology company ...

"The traditional 60/40 investment model is outdated", explains Andrew Peek, CEO and Co-Founder of Delphia which makes quantitative hedge fund strategies available to retail investors for free ...

Delphia, a mobile investment platform, is facing a lawsuit and allegations that its co-founder and CTO Cameron Agius-Westland sexually assaulted and harassed a former employee, according to a ...